|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01652 FUSEN PHARM
Nominal 
0.000 (0.000%) Non-current Assets
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Investment Properties | 14,280 | -7.200% | 15,388 | 16,497 | 17,605 | 18,713 |
| Property, plant, equip. & others | 383,655 | 9.533% | 350,264 | 312,108 | 281,877 | 238,002 |
| Land & other Lease Assets | 237,675 | 1.248% | 234,745 | 217,637 | 224,157 | 247,926 |
| Intangible Assets | 28,135 | 24.762% | 22,551 | 483 | 683 | 883 |
| Interests in Asso. & JCEs | 34,601 | -74.920% | 137,961 | 178,309 | 198,064 | 67,648 |
| Other Non-current Assets | 80,203 | 400.206% | 16,034 | 11,178 | 7,728 | 7,808 |
| 778,549 | 0.207% | 776,943 | 736,212 | 730,114 | 580,980 | |
Current Assets
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | ||
| Inventories | 137,082 | -15.234% | 161,718 | 110,649 | 121,845 | 105,415 | |
| Trade Receivables | 113,878 | -37.935% | 183,482 | 247,189 | 157,581 | 183,930 | |
| Cash & Bank Balances | 21,056 | -39.579% | 34,849 | 128,106 | 81,063 | 297,038 | |
| Other Current Assets | 187,596 | 0.451% | 186,753 | 128,112 | 148,733 | 73,984 | |
| Assets Held for Sale | 0 | -- | 0 | 0 | 0 | 0 | |
| 459,612 | -18.911% | 566,802 | 614,056 | 509,222 | 660,367 | ||
Current Liabilities
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |||
| Trade Payables | 123,466 | -26.309% | 167,545 | 163,613 | 102,115 | 108,585 | ||
| S-T Debt & Leases | 304,464 | 28.118% | 237,643 | 227,949 | 162,748 | 178,500 | ||
| Other Current Liabilities | 344,515 | 32.847% | 259,332 | 330,520 | 224,403 | 260,521 | ||
| Liab asso w/ Assets Held for Sale | 0 | -- | 0 | 0 | 0 | 0 | ||
| 772,445 | 16.241% | 664,520 | 722,082 | 489,266 | 547,606 | |||
| Net Current Assets | (312,833) | 220.139% | (97,718) | (108,026) | 19,956 | 112,761 | ||
| Total Assets Less Current Liabilities | 465,716 | -31.434% | 679,225 | 628,186 | 750,070 | 693,741 | ||
Non-current Liabilities
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | ||||
| L-T Debt & Leases | 79,230 | -25.586% | 106,472 | 432 | 77,940 | 20,000 | |||
| Other Non-current Liabilities | 18,124 | 72.167% | 10,527 | 14,861 | 15,186 | 15,492 | |||
| 97,354 | -16.791% | 116,999 | 15,293 | 93,126 | 35,492 | ||||
Capital and Reserves
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |||||
| Share Capital | 6,179 | -2.076% | 6,310 | 6,383 | 6,479 | 6,513 | ||||
| Reserves | 363,492 | -34.765% | 557,208 | 607,784 | 651,690 | 652,929 | ||||
| Others | 0 | -- | 0 | 0 | 0 | 0 | ||||
| Shareholders' Funds | 369,671 | -34.399% | 563,518 | 614,167 | 658,169 | 659,442 | ||||
| Non-controlling Interests | (1,309) | 1.316% | (1,292) | (1,274) | (1,225) | (1,193) | ||||
| Others | 0 | -- | 0 | 0 | 0 | 0 | ||||
| 368,362 | -34.482% | 562,226 | 612,893 | 656,944 | 658,249 | |||||
Commitments and Contingent Liabilities
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Commitments | -- | -- | 82,205 | 17,634 | 1,819 | 103,617 |
| Contingent Liabilities | -- | -- | 0 | 0 | 0 | 0 |
| Remarks: | Real time quote last updated: 23/04/2025 07:40 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -188,783,000 |
| %Change | 420.393% |
| EPS / (LPS) | RMB -0.260 |
| NBV Per Share (¥) | RMB 0.500 |